Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 14/20 | 0.73 |
| ▸ | TAS1R1 | Q7RTX1 | 13/20 | 0.73 |
| ▸ | TAS1R2 | Q8TE23 | 13/20 | 0.73 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | NAMPT | P43490 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL705624 | 0.84 | TAS1R3 (1.00) | TAS1R3TAS1R1TAS1R2PKMSMN1; SMN2 | |
| SCHEMBL22222488 | 0.76 | PKM (0.83) | TAS1R3TAS1R1TAS1R2PKMSMN1; SMN2 | |
| SCHEMBL4172967 | 0.74 | TAS1R3 (0.82) | TAS1R3TAS1R1TAS1R2PKMSMN1; SMN2 | |
| SCHEMBL20662856 | 0.74 | TAS1R3 (0.79) | TAS1R3TAS1R1TAS1R2PKMSMN1; SMN2 | |
| SCHEMBL21165257 | 0.71 | TAS1R3 (0.51) | TAS1R3TAS1R1TAS1R2PKMSMN1; SMN2 | |
| SCHEMBL2332543 | 0.69 | — | — | |
| SCHEMBL22311455 | 0.69 | — | — | |
| SCHEMBL13350424 | 0.69 | GAA (0.55) | SMN1; SMN2HTTNAMPT | |
| SCHEMBL17865782 | 0.69 | NAMPT (0.58) | SMN1; SMN2HTTNAMPT | |
| SCHEMBL700840 | 0.68 | TAS1R3 (1.00) | TAS1R3TAS1R1TAS1R2PKMSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10352929-B2 | T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds | SENOMYX, INC. (US) | 2019-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10352929-B2 | T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds | TAS1R2, TAS1R1, TAS2R1 | TAS1R3 4/4885TAS1R1 2/4885TAS1R2 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.